Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Eli Lilly & Co. (LLY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | 0 | 0.00 | Sell 100.00% | 0.71 | SEC | ||
| 2025 Q2 | 58,901 | 0.71 | Buy | 0.71 | $779.53 | $45,915,097 | SEC |
| 2024 Q1 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2023 Q4 | 2,002 | 0.02 | Add 22.15% | <0.01 | $582.92 | $1,167,006 | SEC |
| 2023 Q3 | 1,639 | 0.02 | Buy | 0.02 | $537.13 | $880,356 | SEC |
| 2021 Q4 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2021 Q3 | 3,331 | 0.01 | Add 122.36% | <0.01 | $231.16 | $770,000 | SEC |
| 2021 Q2 | 1,498 | <0.01 | Buy | <0.01 | $229.64 | $344,000 | SEC |
| 2020 Q4 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2020 Q3 | 5,349 | 0.01 | Buy | 0.01 | $148.07 | $792,000 | SEC |
| 2003 Q4 | 0 | 0.00 | Sell 100.00% | 0.36 | SEC | ||
| 2003 Q3 | 450,000 | 0.36 | Buy | 0.36 | $59.40 | $26,730,000 | SEC |